• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 25, 2022 at 11:42: PM
via
  • J&J expects its Covid vaccine to generate $3 billion to $3.5 billion in sales this year.
  • The company beat on fourth-quarter earnings but missed on revenue.
  • Its revenue of $24.8 billion rose 10.4% over the same quarter in 2020, mostly driven by $1.82 billion in international sales of its Covid vaccine.

article source
 




Top Bottom
Back
Quote